Paradoxical role of proteinase inhibitors in cystic fibrosis

-antichymotrypsin is associated with less severe pulmonary disease in patients with cystic fibrosis.

By | December 28, 2000

While free proteinases destroy lung tissue in cystic fibrosis, logic predicts that proteinase inhibitors should offer protection. However, for some time doctors have observed that a mild genetic deficiency in an inhibitor is actually associated with a better, rather than worse, outcome. In January's issue of Thorax, Dr Mahadeva and colleagues from the University of Cambridge support this observation with their new findings (Thorax 2001 56:53-58).

They screened 157 patients with cystic fibrosis and identified 10 with a plasma deficiency of α1-antichymotrypsin (plasma concentration <0.2 g/l). In a multivariate analysis these individuals had significantly less severe lung disease than those who had normal or raised levels of α1-antichymotrypsin. They concluded, paradoxical though it may be, that a deficiency of the inhibitor α1-antichymotrypsin is associated with less severe pulmonary disease in patients with cystic fibrosis.

Popular Now

  1. Caloric Restriction Turns White Fat Brown
  2. New Lyme Disease Test Developed by Summer Student
  3. The Neanderthal in the Mirror
    Reading Frames The Neanderthal in the Mirror

    Our evolutionary cousin is no longer a blundering caveman. Recent research has painted a picture of a human ancestor with culture, art, and advanced cognitive skills.

  4. How to Build Bioinformatic Pipelines Using Galaxy
RayBiotech